rs140630401

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001023570.4(IQCB1):​c.1441G>A​(p.Glu481Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00203 in 1,614,138 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. E481E) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0014 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0021 ( 3 hom. )

Consequence

IQCB1
NM_001023570.4 missense

Scores

1
11
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:3B:4

Conservation

PhyloP100: 4.13

Publications

11 publications found
Variant links:
Genes affected
IQCB1 (HGNC:28949): (IQ motif containing B1) This gene encodes a nephrocystin protein that interacts with calmodulin and the retinitis pigmentosa GTPase regulator protein. The encoded protein has a central coiled-coil region and two calmodulin-binding IQ domains. It is localized to the primary cilia of renal epithelial cells and connecting cilia of photoreceptor cells. The protein is thought to play a role in ciliary function. Defects in this gene result in Senior-Loken syndrome type 5. Alternative splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 6. [provided by RefSeq, Jan 2016]
IQCB1 Gene-Disease associations (from GenCC):
  • Senior-Loken syndrome 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Leber congenital amaurosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.05163178).
BP6
Variant 3-121772683-C-T is Benign according to our data. Variant chr3-121772683-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 220867.
BS2
High Homozygotes in GnomAd4 at 4 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IQCB1NM_001023570.4 linkc.1441G>A p.Glu481Lys missense_variant Exon 14 of 15 ENST00000310864.11 NP_001018864.2 Q15051-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IQCB1ENST00000310864.11 linkc.1441G>A p.Glu481Lys missense_variant Exon 14 of 15 1 NM_001023570.4 ENSP00000311505.6 Q15051-1
IQCB1ENST00000349820.10 linkc.1042G>A p.Glu348Lys missense_variant Exon 11 of 12 1 ENSP00000323756.7 Q15051-2
IQCB1ENST00000393650.7 linkn.*419G>A non_coding_transcript_exon_variant Exon 13 of 14 5 ENSP00000377261.3 Q15051-3
IQCB1ENST00000393650.7 linkn.*419G>A 3_prime_UTR_variant Exon 13 of 14 5 ENSP00000377261.3 Q15051-3

Frequencies

GnomAD3 genomes
AF:
0.00143
AC:
218
AN:
152166
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00295
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000566
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00216
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00110
AC:
277
AN:
251410
AF XY:
0.00102
show subpopulations
Gnomad AFR exome
AF:
0.000738
Gnomad AMR exome
AF:
0.00104
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.00193
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.00210
AC:
3066
AN:
1461854
Hom.:
3
Cov.:
32
AF XY:
0.00197
AC XY:
1433
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33478
American (AMR)
AF:
0.00103
AC:
46
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86258
European-Finnish (FIN)
AF:
0.000281
AC:
15
AN:
53416
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5756
European-Non Finnish (NFE)
AF:
0.00259
AC:
2879
AN:
1111996
Other (OTH)
AF:
0.00180
AC:
109
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
170
340
510
680
850
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
118
236
354
472
590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00143
AC:
218
AN:
152284
Hom.:
4
Cov.:
32
AF XY:
0.00141
AC XY:
105
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41556
American (AMR)
AF:
0.00294
AC:
45
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
0.000566
AC:
6
AN:
10606
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00216
AC:
147
AN:
68026
Other (OTH)
AF:
0.00142
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00181
Hom.:
1
Bravo
AF:
0.00164
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.00337
AC:
13
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00186
AC:
16
ExAC
AF:
0.00109
AC:
132
EpiCase
AF:
0.00234
EpiControl
AF:
0.00166

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:3Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Senior-Loken syndrome 5 Uncertain:2Benign:1
May 21, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 05, 2020
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

not provided Uncertain:1Benign:1
May 30, 2023
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32483926, 30718709, 22261762, 31738409, 22773737, 34426522) -

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

IQCB1: BS1 -

Retinitis pigmentosa Pathogenic:1
Apr 01, 2018
Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:research

- -

Nephronophthisis Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

IQCB1-related disorder Benign:1
Jul 13, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Uncertain
0.070
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.095
T;.
Eigen
Uncertain
0.67
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.89
D;D
M_CAP
Benign
0.061
D
MetaRNN
Benign
0.052
T;T
MetaSVM
Uncertain
0.071
D
MutationAssessor
Uncertain
2.6
M;.
PhyloP100
4.1
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-1.9
N;D
REVEL
Uncertain
0.56
Sift
Uncertain
0.0040
D;D
Sift4G
Uncertain
0.013
D;D
Polyphen
0.96
P;D
Vest4
0.61
MVP
0.92
MPC
0.23
ClinPred
0.049
T
GERP RS
5.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.16
gMVP
0.39
Mutation Taster
=24/76
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140630401; hg19: chr3-121491530; API